Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from ProAssurance ( (PRA) ).
On August 5, 2025, ProAssurance Corporation reported its financial results for the second quarter of 2025, highlighting a net income of $21.9 million and operating income of $26.8 million. The company demonstrated progress in achieving premium rate levels suitable for the challenging medical professional liability market, with a stable net premium written of $135.9 million. The quarter also saw a 10% increase in Specialty P&C renewal premiums and an improvement in the consolidated Non-GAAP combined ratio by 9.5 percentage points compared to the previous year. Additionally, the company announced a merger with The Doctors Company, which received stockholder approval and early termination of the waiting period under the Hart-Scott-Rodino Act, with the transaction expected to close in the first half of 2026.
The most recent analyst rating on (PRA) stock is a Hold with a $14.00 price target. To see the full list of analyst forecasts on ProAssurance stock, see the PRA Stock Forecast page.
Spark’s Take on PRA Stock
According to Spark, TipRanks’ AI Analyst, PRA is a Neutral.
ProAssurance’s overall score reflects a balance of factors. The acquisition by The Doctors Company is a significant positive, potentially leading to strategic benefits. However, high valuation metrics and cash flow issues pose risks. Technical analysis provides a mixed outlook, suggesting caution in the near term.
To see Spark’s full report on PRA stock, click here.
More about ProAssurance
ProAssurance Corporation is a leading specialty insurer with significant expertise in medical professional liability. The company primarily focuses on providing insurance solutions in the medical professional liability and workers’ compensation markets.
Average Trading Volume: 570,374
Technical Sentiment Signal: Buy
Current Market Cap: $1.21B
See more data about PRA stock on TipRanks’ Stock Analysis page.